The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders

Akil, 1993, Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin, Biol Psychiatry, 33, 73, 10.1016/0006-3223(93)90305-W Alim, 2006, Trauma exposure, posttraumatic stress disorder and depression in an African-American primary care population, J Natl Med Assoc, 98, 1630 Barden, 1997, Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor, Neuroendocrinology, 66, 212, 10.1159/000127240 Billing, 2007, Proteomic analysis of the cortisol-mediated stress response in THP-1 monocytes using DIGE technology, J Mass Spectrom, 42, 1433, 10.1002/jms.1270 Binder, 2008, Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults, JAMA, 299, 1, 10.1001/jama.299.11.1291 Binder, 2004, Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment, Nat Genet, 36, 1319, 10.1038/ng1479 Boyle, 2005, Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior, Proc Natl Acad Sci U S A, 102, 473, 10.1073/pnas.0406458102 Brady, 1991, Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications, J Clin Invest, 87, 831, 10.1172/JCI115086 Broekman, 2007, The genetic background to PTSD, Neurosci Biobehav Rev, 31, 348, 10.1016/j.neubiorev.2006.10.001 Carroll, 1984, Dexamethasone suppression test for depression, Adv Biochem Psychopharmacol, 39, 179 Davidson, 2004, Posttraumatic stress disorder: acquisition, recognition, course, and treatment, J Neuropsychiatry Clin Neurosci, 16, 135, 10.1176/appi.neuropsych.16.2.135 Davies, 2002, A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins, J Biol Chem, 277, 4597, 10.1074/jbc.C100531200 Denny, 2000, Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding, Endocrinology, 141, 4107, 10.1210/en.141.11.4107 Frances, 1994 Gawlik, 2006, Is FKBP5 a genetic marker of affective psychosis? A case control study and analysis of disease related traits, BMC Psychiatry, 6, 52, 10.1186/1471-244X-6-52 Gillespie, 2005, Emotional learning and glutamate: translational perspectives, CNS Spectr, 10, 831, 10.1017/S1092852900010439 Grad, 2007, The glucocorticoid responses are shaped by molecular chaperones, Mol Cell Endocrinol, 275, 2, 10.1016/j.mce.2007.05.018 Heim, 2009, Neurobiology of posttraumatic stress disorder, CNS Spectr, 14, 13 Hennings, 2009, Clinical characteristics and treatment outcome in a representative sample of depressed inpatients—findings from the Munich Antidepressant Response Signature (MARS) project, J Psychiatr Res, 43, 215, 10.1016/j.jpsychires.2008.05.002 Heuser, 1994, The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders, J Psychiatr Res, 28, 341, 10.1016/0022-3956(94)90017-5 Heuser, 1996, Pituitary–adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects, Am J Psychiatry, 153, 93, 10.1176/ajp.153.1.93 Hoge, 2004, Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care, N Engl J Med, 351, 13, 10.1056/NEJMoa040603 Holsboer, 1999, The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety, J Psychiatr Res, 33, 181, 10.1016/S0022-3956(98)90056-5 Holsboer, 2000, The corticosteroid receptor hypothesis of depression, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 Holsboer, 1982, Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement, J Affect Disord, 4, 93, 10.1016/0165-0327(82)90039-8 Horstmann, 2009, Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action, Psychoneuroendocrinology, 34, 238, 10.1016/j.psyneuen.2008.09.004 Hubler, 2003, The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness, Endocrinology, 144, 2380, 10.1210/en.2003-0092 Hubler, 2004, Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids, Cell Stress Chaperones, 9, 243, 10.1379/CSC-32R.1 Ising, 2008, Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls, Eur J Neurosci, 28, 389, 10.1111/j.1460-9568.2008.06332.x Ising, 2007, Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression—a potential biomarker?, Biol Psychiatry, 62, 47, 10.1016/j.biopsych.2006.07.039 Ising, 2005, The combined dexamethasone/CRH test as a potential surrogate marker in depression, Prog Neuropsychopharmacol Biol Psychiatry, 29, 1085, 10.1016/j.pnpbp.2005.03.014 Kato, 2007, Molecular genetics of bipolar disorder and depression, Psychiatry Clin Neurosci, 61, 3, 10.1111/j.1440-1819.2007.01604.x Keane, 2006, Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome, Annu Rev Clin Psychol, 2, 161, 10.1146/annurev.clinpsy.2.022305.095305 Kendler, 1995, Genetic epidemiology in psychiatry. Taking both genes and environment seriously, Arch Gen Psychiatry, 52, 895, 10.1001/archpsyc.1995.03950230009003 Kilpatrick, 2007, The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults, Am J Psychiatry, 164, 1693, 10.1176/appi.ajp.2007.06122007 Kirchheiner, 2008, Genetic variants in FKBP5 affecting response to antidepressant drug treatment, Pharmacogenomics, 9, 841, 10.2217/14622416.9.7.841 Koenen, 2005, Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children, Mol Psychiatry, 10, 1058, 10.1038/sj.mp.4001727 Lekman, 2008, The FKBP5-gene in depression and treatment response—an association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort, Biol Psychiatry, 63, 1103, 10.1016/j.biopsych.2007.10.026 Maeng, 2008, BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments, Proc Natl Acad Sci U S A, 105, 8766, 10.1073/pnas.0803736105 Magee, 2006, Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element, Endocrinology, 147, 590, 10.1210/en.2005-1001 Montkowski, 1995, Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function, J Neuroendocrinol, 7, 841, 10.1111/j.1365-2826.1995.tb00724.x Nair, 1997, Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor, Mol Cell Biol, 17, 594, 10.1128/MCB.17.2.594 Nemeroff, 1996, The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions, Mol Psychiatry, 1, 336 Ozer, 2003, Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis, Psychol Bull, 129, 52, 10.1037/0033-2909.129.1.52 Papiol, 2007, Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment, J Affect Disord, 104, 83, 10.1016/j.jad.2007.02.017 Pariante, 2001, Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment, Biol Psychiatry, 49, 391, 10.1016/S0006-3223(00)01088-X Pariante, 2004, Do antidepressants regulate how cortisol affects the brain?, Psychoneuroendocrinology, 29, 423, 10.1016/j.psyneuen.2003.10.009 Peeters, 2004, Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice, Brain Res Mol Brain Res, 129, 135, 10.1016/j.molbrainres.2004.06.038 Pepin, 1992, Increased glucocorticoid receptor gene promoter activity after antidepressant treatment, Mol Pharmacol, 41, 1016 Pitman, 2005, Conceptually driven pharmacologic approaches to acute trauma, CNS Spectr, 10, 99, 10.1017/S109285290001943X Pratt, 2006, Chaperoning of glucocorticoid receptors, Handb Exp Pharmacol, 111, 10.1007/3-540-29717-0_5 Pratt, 1997, Steroid receptor interactions with heat shock protein and immunophilin chaperones, Endocr Rev, 18, 306, 10.1210/er.18.3.306 Reul, 1994, Hypothalamic–pituitary–adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide, Neuroendocrinology, 60, 509, 10.1159/000126788 Reul, 1993, Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic–pituitary–adrenocortical system, Endocrinology, 133, 312, 10.1210/en.133.1.312 Ridder, 2005, Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions, J Neurosci, 25, 6243, 10.1523/JNEUROSCI.0736-05.2005 Rothbaum, 2003, Applying learning principles to the treatment of post-trauma reactions, Ann N Y Acad Sci, 1008, 112, 10.1196/annals.1301.012 Scammell, 2001, Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates, Gen Comp Endocrinol, 124, 152, 10.1006/gcen.2001.7696 Schiene-Fischer, 2001, Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases., FEBS Lett, 495, 1, 10.1016/S0014-5793(01)02326-2 Schule, 2009, The combined dexamethasone/CRH test (DEX/CRH test) and prediction of acute treatment response in major depression, PLoS ONE, 4, e4324, 10.1371/journal.pone.0004324 Seckl, 1992, Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo, Neuroendocrinology, 55, 621, 10.1159/000126180 Segman, 2005, Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors, Mol Psychiatry, 10, 425, 10.1038/sj.mp.4001676 Stein, 2002, Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study, Am J Psychiatry, 159, 1675, 10.1176/appi.ajp.159.10.1675 Strohle, 2003, Stress responsive neurohormones in depression and anxiety, Pharmacopsychiatry, 36, S207 Szymanska, 2009, The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats, Psychoneuroendocrinology, 34, 822, 10.1016/j.psyneuen.2008.12.012 Tatro, 2009, Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder, J Neuroimmune Pharmacol, 4, 218, 10.1007/s11481-009-9146-6 Tsai, 2007, Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment, Am J Med Genet B Neuropsychiatr Genet, 144, 1097, 10.1002/ajmg.b.30246 Tsatsanis, 2007, The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function, Cell Mol Life Sci, 64, 1638, 10.1007/s00018-007-6555-7 U, 2004, Identification of novel direct transcriptional targets of glucocorticoid receptor, Leukemia, 18, 1850, 10.1038/sj.leu.2403516 Vale, 1981, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin, Science, 213, 1394, 10.1126/science.6267699 Valentino, 1983, Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus, Brain Res, 270, 363, 10.1016/0006-8993(83)90615-7 Vermeer, 2003, Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability, J Clin Endocrinol Metab, 88, 277, 10.1210/jc.2002-020354 von Bardeleben, 1991, Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone, Biol Psychiatry, 29, 1042, 10.1016/0006-3223(91)90360-X Watson, 2002, Hypothalamic–pituitary–adrenal axis function in patients with chronic depression, Psychol Med, 32, 1021, 10.1017/S0033291702005998 Westberry, 2006, Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51, J Steroid Biochem Mol Biol, 100, 34, 10.1016/j.jsbmb.2006.03.004 Willour, 2009, Family-based association of FKBP5 in bipolar disorder, Mol Psychiatry, 14, 261, 10.1038/sj.mp.4002141 Wochnik, 2005, FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells, J Biol Chem, 280, 4609, 10.1074/jbc.M407498200 Woodruff, 2007, Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids, Proc Natl Acad Sci U S A, 104, 15858, 10.1073/pnas.0707413104 Yehuda, 2001, Biology of posttraumatic stress disorder, J Clin Psychiatry, 62, 41 Yehuda, 2009, Gene expression patterns associated with posttraumatic stress disorder following exposure to the world trade center attacks, Biol Psychiatry, 10.1016/j.biopsych.2009.02.034 Yehuda, 1991, Hypothalamic–pituitary–adrenal dysfunction in posttraumatic stress disorder, Biol Psychiatry, 30, 1031, 10.1016/0006-3223(91)90123-4 Yehuda, 2004, The ACTH response to dexamethasone in PTSD, Am J Psychiatry, 161, 1397, 10.1176/appi.ajp.161.8.1397 Yehuda, 2004, Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder, Biol Psychiatry, 55, 1110, 10.1016/j.biopsych.2004.02.010 Zhang, 2008, FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness, Invest Ophthalmol Vis Sci, 49, 1037, 10.1167/iovs.07-1279